
Opinion|Videos|October 16, 2026
Consent Conversations and Discussion of Bridging Therapy
One panelist describes the consent conversation with patients and caregivers, including how the treatment works, what to expect from outcomes, the practical process, and side effects such as cytokine release syndrome, ICANS, cranial nerve palsy, colitis, and movement disorders.
Advertisement
Episodes in this series

One panelist describes the consent conversation with patients and caregivers, including how the treatment works, what to expect from outcomes, the practical process, and side effects such as cytokine release syndrome, ICANS, cranial nerve palsy, colitis, and movement disorders. The faculty then discuss bridging therapy, including aiming for a response before infusion and options available in earlier lines.
Advertisement
Related to this article

Erik Bengtsen, MD, explained how antidepressants may improve quality of life and how he typically works with patients who decline favorable treatment.

Erik Bengtsen, MD, shares a key depression screening question and explains when oncologists can start a low-dose antidepressant.
Advertisement
Advertisement
Trending on CancerNetwork
1
VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors
2
Personalized Cancer Vaccine Combo Is Feasible in Platinum-Sensitive Ovarian Cancer
3
Proton Therapy Tied to Less Hypothyroidism After Supraclavicular Breast RT
4
ASH Issues New Myelofibrosis Guidelines With 10 Management Recommendations
5

